The Globe and Mail reports in its Tuesday edition that Desjardins Securities analyst Brent Stadler continues to rate Boralex "buy." The Globe's David Leeder writes in the Eye On Equities column that Mr. Stadler boosted his share target by a loonie to $45. Analysts on average target the shares at $44.85. The Globe reports that Mr. Stadler thinks investors should be buying Boralex at current levels following the closing of a $608-million financing for its Apuiat wind farm on Quebec's North Shore and the securing of a 15-year offtake for its Limekiln wind farm in Scotland. He points to "solid project economics and the recent data point suggesting that a high-quality wind platform should trade closer to 13 times plus. He also believes the Montreal-based company is making progress toward its 2025 growth targets. Mr. Stadler says in a note: "The announcements on Sept. 8 significantly derisked Boralex's two largest projects in its under-construction/ready-to-build bucket. Combined, we expect the two projects to generate approximately $60-million of EBITDA and $20-million-plus of FCF net to Boralex. These projects represent 208MW of Boralex's 319MW of projects expected to be on-line by roughly the end of 2024."